ABSORPTION, HALF-LIFE, AND TOXICITY OF ORAL APRINDINE IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION

被引:20
作者
HAGEMEIJER, F [1 ]
机构
[1] ERASMUS UNIV,THORAX CTR,ROTTERDAM,NETHERLANDS
关键词
D O I
10.1007/BF00613425
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:21 / 25
页数:5
相关论文
共 17 条
[11]   PHARMACOKINETICS OF PROCAINAMIDE IN MAN [J].
KOCHWESER, J .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1971, 179 (JUL6) :370-+
[12]   LIDOCAINE IN PREVENTION OF PRIMARY VENTRICULAR-FIBRILLATION - DOUBLE-BLIND, RANDOMIZED STUDY OF 212 CONSECUTIVE PATIENTS [J].
LIE, KI ;
WELLENS, HJ ;
VANCAPEL.FJ ;
DURRER, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (25) :1324-1326
[13]  
LOVELL R R H, 1971, Progress in Cardiovascular Diseases, V13, P482, DOI 10.1016/0033-0620(71)90013-2
[14]  
PITT A, 1971, LANCET, V1, P612
[15]   COMPARATIVE MECHANISMS OF ACTION OF ANTIARRHYTHMIC DRUGS [J].
SINGH, BN ;
HAUSWIRTH, O .
AMERICAN HEART JOURNAL, 1974, 87 (03) :367-382
[16]  
TALBOT RG, 1973, LANCET, V2, P399
[17]   THERAPEUTIC EFFECTIVENESS AND PLASMA-LEVELS OF APRINDINE, A NEW ANTIDYSRHYTHMIC DRUG [J].
VANDURME, JP ;
BOGAERT, MG ;
ROSSEEL, MT .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 7 (05) :343-346